Literature DB >> 19066574

Labeling hESCs and hMSCs with iron oxide nanoparticles for non-invasive in vivo tracking with MR imaging.

Tobias D Henning1, Sophie Boddington, Heike E Daldrup-Link.   

Abstract

In recent years, stem cell research has led to a better understanding of developmental biology, various diseases and its potential impact on regenerative medicine. A non-invasive method to monitor the transplanted stem cells repeatedly in vivo would greatly enhance our ability to understand the mechanisms that control stem cell death and identify trophic factors and signaling pathways that improve stem cell engraftment. MR imaging has been proven to be an effective tool for the in vivo depiction of stem cells with near microscopic anatomical resolution. In order to detect stem cells with MR, the cells have to be labeled with cell specific MR contrast agents. For this purpose, iron oxide nanoparticles, such as superparamagnetic iron oxide particles (SPIO), are applied, because of their high sensitivity for cell detection and their excellent biocompatibility. SPIO particles are composed of an iron oxide core and a dextran, carboxydextran or starch coat, and function by creating local field inhomogeneities, that cause a decreased signal on T2-weighted MR images. This presentation will demonstrate techniques for labeling of stem cells with clinically applicable MR contrast agents for subsequent non-invasive in vivo tracking of the labeled cells with MR imaging.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066574      PMCID: PMC2586865          DOI: 10.3791/685

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

1.  Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Guido Piontek; Stephan Metz; Rosalinde Bräuer; Gerlinde Debus; Claire Corot; Jürgen Schlegel; Thomas M Link; Christian Peschel; Ernst J Rummeny; Robert A J Oostendorp
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

2.  Cell labeling with the positive MR contrast agent Gadofluorine M.

Authors:  Tobias D Henning; Olaf Saborowski; Daniel Golovko; Sophie Boddington; Jan S Bauer; Yanjun Fu; Reinhard Meier; Hubertus Pietsch; Barbara Sennino; Donald M McDonald; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

3.  Targeting of hematopoietic progenitor cells with MR contrast agents.

Authors:  Heike E Daldrup-Link; Martina Rudelius; Robert A J Oostendorp; Marcus Settles; Guido Piontek; Stefan Metz; Hilkea Rosenbrock; Ulrich Keller; Ulrich Heinzmann; Ernst J Rummeny; Jürgen Schlegel; Thomas M Link
Journal:  Radiology       Date:  2003-07-24       Impact factor: 11.105

  3 in total
  11 in total

1.  In situ tissue engineering using magnetically guided three-dimensional cell patterning.

Authors:  Shawn P Grogan; Chantal Pauli; Peter Chen; Jiang Du; Christine B Chung; Seong Deok Kong; Clifford W Colwell; Martin K Lotz; Sungho Jin; Darryl D D'Lima
Journal:  Tissue Eng Part C Methods       Date:  2012-02-10       Impact factor: 3.056

2.  Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques.

Authors:  Yingli Fu; Nicole Azene; Yi Xu; Dara L Kraitchman
Journal:  Imaging Med       Date:  2011-08-01

Review 3.  Imaging approaches for the study of cell-based cardiac therapies.

Authors:  Joe F Lau; Stasia A Anderson; Eric Adler; Joseph A Frank
Journal:  Nat Rev Cardiol       Date:  2009-12-22       Impact factor: 32.419

4.  Implantation of ferumoxides labeled human mesenchymal stem cells in cartilage defects.

Authors:  Alexander J Nedopil; Lydia G Mandrussow; Heike E Daldrup-Link
Journal:  J Vis Exp       Date:  2010-04-05       Impact factor: 1.355

5.  Labeling stem cells with ferumoxytol, an FDA-approved iron oxide nanoparticle.

Authors:  Rosalinda T Castaneda; Aman Khurana; Ramsha Khan; Heike E Daldrup-Link
Journal:  J Vis Exp       Date:  2011-11-04       Impact factor: 1.355

6.  Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging.

Authors:  Rosalinda T Castaneda; Sophie Boddington; Tobias D Henning; Mike Wendland; Lydia Mandrussow; Siyuan Liu; Heike Daldrup-Link
Journal:  Pediatr Radiol       Date:  2011-05-19

Review 7.  Non-invasive imaging of human embryonic stem cells.

Authors:  Hao Hong; Yunan Yang; Yin Zhang; Weibo Cai
Journal:  Curr Pharm Biotechnol       Date:  2010-09-01       Impact factor: 2.837

8.  Ferumoxytol: a new, clinically applicable label for stem-cell tracking in arthritic joints with MRI.

Authors:  Aman Khurana; Hossein Nejadnik; Fanny Chapelin; Olga Lenkov; Rakhee Gawande; Sungmin Lee; Sandeep N Gupta; Nooshin Aflakian; Nikita Derugin; Solomon Messing; Guiting Lin; Tom F Lue; Laura Pisani; Heike E Daldrup-Link
Journal:  Nanomedicine (Lond)       Date:  2013-03-27       Impact factor: 5.307

9.  Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth.

Authors:  Carolina Belmar-Lopez; Gracia Mendoza; Daniel Oberg; Jerome Burnet; Carlos Simon; Irene Cervello; Maite Iglesias; Juan Carlos Ramirez; Pilar Lopez-Larrubia; Miguel Quintanilla; Pilar Martin-Duque
Journal:  BMC Med       Date:  2013-05-28       Impact factor: 8.775

10.  MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects.

Authors:  Hossein Nejadnik; Tobias D Henning; Thuy Do; Elizabeth J Sutton; Frederick Baehner; Andrew Horvai; Barbara Sennino; Donald McDonald; Reinhard Meier; Bernd Misselwitz; Thomas M Link; Heike E Daldrup-Link
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.